ClinConnect ClinConnect Logo
Search / Trial NCT00547989

Paravertebral Block, an Adjunct to General Anaesthesia for Breast Surgery?

Launched by MAASTRICHT UNIVERSITY MEDICAL CENTER · Oct 22, 2007

Trial Information

Current as of May 02, 2025

Completed

Keywords

Asa Class I And Ii

ClinConnect Summary

Usually breast tumour surgery in the Academic Hospital Maastricht is performed under general anaesthesia. Perioperative pain management consists of paracetamol and naproxen preoperatively, opioids during surgery and local wound infiltration at the end of surgery with 10cc Bupivacaine 0.25%. Postoperative pain management consists of paracetamol, occasionally combined with Naproxen, and if necessary Piritramide 0.2 mg/kg i.m.

Alternatively there is the possibility to perform breast surgery under a thoracic paravertebral block (PVB) with or without general anesthesia.

A PVB according to Easo...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Extended mamma surgery one-sided
  • ASA class I and II
  • Exclusion Criteria:
  • All contra indications for local anaesthesia
  • Coagulation disorders
  • Infection
  • Allergic reactions

About Maastricht University Medical Center

Maastricht University Medical Center (MUMC+) is a leading academic medical center in the Netherlands, renowned for its commitment to advancing healthcare through innovative research and education. As a prominent sponsor of clinical trials, MUMC+ integrates cutting-edge scientific inquiry with clinical practice, focusing on a wide range of medical disciplines. The center emphasizes collaboration among multidisciplinary teams, fostering an environment that promotes excellence in patient care and the translation of research findings into clinical applications. MUMC+ is dedicated to improving health outcomes and enhancing quality of life through rigorous clinical investigations and the development of novel therapeutic strategies.

Locations

Maastricht, , Netherlands

Patients applied

0 patients applied

Trial Officials

Esther Bouman, MD

Principal Investigator

azM

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials